Research Article

Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes

Table 4

Risk factors for bleeding events defined by the BARC criteria in ACS patients with diabetes in multivariable analysis.

VariableMultivariable OR (95% CI) valueMultivariable OR (95% CI) value

Age, years0.97 (0.93–1.00)0.0560.97 (0.94–1.00)0.068
History
 Chronic kidney disease0.37 (0.11–1.29)0.1200.39 (0.12–1.26)0.117
Biomedical indicator
 Triglyceride1.13 (0.94–1.35)0.2041.11 (0.98–1.27)0.107
Grouping (ticagrelor vs. clopidogrel)1.80 (0.95–3.41)0.0701.76 (1.00–3.10)0.049

95% CI: 95% confidence interval; OR: odds ratio; : logistic regression analysis; : Cox survival analysis; BMI: body mass index; MI: myocardial infarction; GI: gastrointestinal; RAAS: renin-angiotensin-aldosterone system; ALT: alanine aminotransferase; eGFR: estimated glomerular filtration rate.